Suppr超能文献

乳癖平预防乳腺癌复发和转移的临床观察

[Clinical observation of Ruyiping in preventing recidivation and metastasis of breast cancer].

作者信息

Liu Sheng, Hua Yong-qiang, Sun Zhen-ping, Tan Song, Lu De-ming

机构信息

Department of Breast Surgery, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.

出版信息

Zhong Xi Yi Jie He Xue Bao. 2007 Mar;5(2):147-9.

Abstract

OBJECTIVE

To observe the effect of Ruyiping, a traditional Chinese compound herbal medicine composed of 5 Chinese herbs for removing toxic materials and dissipating nodules from Runing II, another traditional Chinese compound herbal medicine for treating breast cancer, in preventing recidivation and metastasis in breast cancer patients after operation.

METHODS

Eighty patients with breast cancer after operation were randomly divided into Ruyiping group and Runing II group, and prescribed Ruyiping and Runing II on the basis of chemotherapy, radiotherapy and endocrine therapy respectively for two years.

RESULTS

There were two patients with metastasis and three patients lost to follow-up in Ruyiping group and three and two in Runing II group. The recidivation and metastasis rates were 5.41% and 7.89% respectively. The difference between the two groups was not statistically significant (P>0.05). The difference of disease-free survival time between the two groups was also not statistically significant.

CONCLUSIONS

The effect of Ruyiping in preventing recidivation and metastasis is similar to that of Runing II. Ruyiping is the essential component of Runing II for preventing recidivation and metastasis. The result provides some clinical evidences for the theory that "Yudu Pangcuan" (vestigial poison invasion elsewhere) is the essential pathogenesis of breast cancer's recidivation and metastasis and the utilization of "Sanjie Jiedu" (dispersing accumulation and detoxification) is the therapeutic principle in preventing recidivation and metastasis after operation.

摘要

目的

观察由5味中药组成的具有解毒散结作用的中药复方制剂乳癖平对另一治疗乳腺癌的中药复方制剂乳宁Ⅱ预防乳腺癌患者术后复发转移的作用。

方法

80例乳腺癌术后患者随机分为乳癖平组和乳宁Ⅱ组,分别在化疗、放疗及内分泌治疗基础上服用乳癖平和乳宁Ⅱ,疗程均为2年。

结果

乳癖平组有2例发生转移,3例失访;乳宁Ⅱ组有3例发生转移,2例失访。复发转移率分别为5.41%和7.89%,两组差异无统计学意义(P>0.05)。两组无病生存时间差异也无统计学意义。

结论

乳癖平预防复发转移的作用与乳宁Ⅱ相似,乳癖平是乳宁Ⅱ预防复发转移的核心组成部分。本研究结果为“余毒旁窜”是乳腺癌复发转移的核心病机、“散结解毒”是预防术后复发转移的治疗原则提供了临床依据。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验